Influence of BAK-Preserved Prostaglandin Analog Treatment on the Ocular Surface Health in Patients with Newly Diagnosed Primary Open-Angle Glaucoma

<table>Percentage of newly diagnosed POAG patients with ocular surface disease index (OSDI) scores indicating normal ocular surface or the presence of mild, moderate, or severe ocular surface disease assessed at baseline and after 3 months.</table>

BioMed Research International

fig3

Figure 3

Figure 3: Influence of BAK-Preserved Prostaglandin Analog Treatment on the Ocular Surface Health in Patients with Newly Diagnosed Primary Open-Angle Glaucoma 

Figure 3 | Influence of BAK-Preserved Prostaglandin Analog Treatment on the Ocular Surface Health in Patients with Newly Diagnosed Primary Open-Angle Glaucoma 